Outcomes in patients with chronic kidney disease not on dialysis receiving extended dosing regimens of darbepoetin alfa: long-term results of the EXTEND observational cohort study

BACKGROUND: Extended dosing of the erythropoiesis-stimulating agent (ESA) darbepoetin alfa (DA) once biweekly or monthly reduces anaemia treatment burden. This observational study assessed outcomes and dosing patterns in patients with chronic kidney disease not on dialysis (CKD-NoD) commencing exten...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nephrol Dial Transplant
Auteurs principaux: Galle, Jan-Christoph, Addison, Janet, Suranyi, Michael G., Claes, Kathleen, Di Giulio, Salvatore, Guerin, Alain, Herlitz, Hans, Kiss, István, Farouk, Mourad, Manamley, Nick, Wirnsberger, Gerhard, Winearls, Christopher
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2016
Sujets:
CLINICAL SCIENCE
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146706/
https://ncbi.nlm.nih.gov/pubmed/27190334
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw047
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires